SPY766.62−0.02%QQQ689.02−0.42%BTC/USD80,406.06−0.03%DIA534.30+0.22%GLD374.79+0.62%TLT81.92+0.20%

Premium Services

Core Laboratories Inc

CLBNYSE

Trade with Public

Trade with Public

$9.65

-0.12-1.23%

Last update: Nov 4, 4:00 PM

Overview News Earnings ForecastPrice TargetsFinancials Sentiment Ownership Dividends Compare Options Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Core Laboratories (CLB) Stock Price Target 2026

The average analyst price target for Core Laboratories is $14.25, 47.7% above the current price. Of 4 analysts, 3 rate it Hold and 1 Sell. Targets range from $12 to $17. The latest change came on Jul 16, 2025, when Stifel lowered its price target on Core Laboratories from $13 to $12 and kept a Hold rating.

The Average Analyst Price Target for Core Laboratories is $14.25.

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

3Hold

1Sell

Consensus RatingNeutral# Analysts4Avg. Consensus PT$14.25Upside to Avg. PT+47.7%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Core Laboratories Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 16, 2025	Stifel	Stephen Gengaro	PT Cut	Hold	$13→$12
May 13, 2025	Citigroup	Scott Gruber	PT Cut	Neutral	$16→$13
Apr 15, 2025	Stifel	Stephen Gengaro	PT Cut	Hold	$19→$15
Mar 12, 2025	Citigroup	Scott Gruber	Upgrade	Sell→Neutral	$15→$16
Feb 20, 2025	Citigroup	Scott Gruber	PT Raise	Sell	$14→$15
Oct 31, 2024	Citigroup	Scott Gruber	PT Cut	Sell	$15→$14
Jul 26, 2024	Stifel	Stephen Gengaro	PT Raise	Hold	$18→$22
Jul 15, 2024	B of A Securities	Chase Mulvehill	PT Cut	Underperform	$16→$15
Jul 15, 2024	Piper Sandler	Luke Lemoine	PT Cut	Neutral	$18→$17
Apr 26, 2024	Stifel	Stephen Gengaro	PT Raise	Hold	$17→$18
Apr 15, 2024	B of A Securities	Chase Mulvehill	PT Cut	Underperform	$17→$16
Feb 5, 2024	Stifel	Stephen Gengaro	PT Cut	Hold	$21→$17
Jan 29, 2024	Stifel	Stephen Gengaro	PT Cut	Hold	$23→$21

Analyst Ratings News

PRO
Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $12

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $13 to $12.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Core Laboratories, Lowers Price Target to $13

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Neutral and lowers the price target from $16 to $13.

Benzinga Newsdesk

PRO
Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $15

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $19 to $15.

Benzinga Newsdesk

PRO
Citigroup Upgrades Core Laboratories to Neutral, Raises Price Target to $16

Citigroup analyst Scott Gruber upgrades Core Laboratories (NYSE:CLB) from Sell to Neutral and raises the price target from $15 to $16.

Benzinga Newsdesk

PRO
Citigroup Maintains Sell on Core Laboratories, Raises Price Target to $15

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and raises the price target from $14 to $15.

Benzinga Newsdesk

PRO
Citigroup Maintains Sell on Core Laboratories, Lowers Price Target to $14

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and lowers the price target from $15 to $14.

Benzinga Newsdesk